Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EBIO: Epoch Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: JR who wrote (7)	12/28/2000 4:04:05 PM
From: tuck	Read Replies (1) \| Respond to of 33

JR, I concur that both bear market and year end pressures are adding to the drop. Re: TRGA: it actually got a substantial premium, but that's because it had drifted into penny stock status. Compare the take out price of $1.35/share to the 52 week range for an idea of how little anyone made on this take out. Implication; such companies are not in favor. To be fair, I am not sure how good a comp TRGA is for EBIO, but they're in the same forest, if not the same grove. Message 15085356 Cheers, Tuck